FORENSIC TOXICOLOGY - Bio Medical Forensics
FORENSIC TOXICOLOGY - Bio Medical Forensics
FORENSIC TOXICOLOGY - Bio Medical Forensics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
K8 Purity of Street Ketamine Preparations<br />
Retrieved From Night Club Amnesty Bins<br />
in London<br />
John Ramsey, MSc, TIC TAC Communications Ltd., St. Georges<br />
University of London, Cramner Terrace, London, SW17 0RE, UNITED<br />
KINGDOM; and Michael D. Osselton, and Eva M. Reichardt, MSc*,<br />
Bournemouth University, Talbot Campus, Fern Barrow, Poole, BH12<br />
5BB, UNITED KINGDOM<br />
The goals of this presentation are to describe the analysis of street<br />
ketamine in order to determine the purity of samples commonly<br />
available and to identify what impurities might be present.<br />
This presentation will impact the forensic science community by<br />
showing how the majority of street ketamine samples analyzed were of<br />
high percentage purity suggesting that ketamine may be responsible for<br />
effects on the urogenital system. This also supports the observation that<br />
a number of patients undergoing clinical therapy with ketamine have<br />
reported similar symptoms.<br />
Introduction: Ketamine has been widely used in medicine and<br />
veterinary practice for its anesthetic and analgesic properties linked with<br />
minimal respiratory depression. More recently the drug has gained<br />
popularity as a recreational substance amongst young people. Street<br />
prices of the drug vary between £10 and £20 per gram in the UK. The<br />
UK club magazine Mixmag survey of its readers in 2009 shows 51%<br />
used ketamine in last year, 32% in last month and 18% use it weekly.<br />
30% experienced stomach pains after taking ketamine and 20%<br />
experienced urinary tract problems (more in women). A number of<br />
reports have appeared in the medical literature suggesting a possible link<br />
between ketamine misuse and kidney and bladder disorders. The<br />
pathological cause of the bladder related problems is at present unknown<br />
and it is uncertain whether they are attributable to ketamine or to<br />
impurities that may be present in street preparations. Little information<br />
is available concerning the purity of street ketamine hence analysis was<br />
undertaken on street preparations of the drug retrieved from amnesty<br />
bins in London night clubs. In this paper, the analysis of street ketamine<br />
is described to determine the purity of samples commonly available and<br />
to identify what impurities might be present.<br />
Method: Street ketamine samples were analyzed using HPLC with<br />
diode-array in order to determine the percentage of ketamine present in<br />
the sample and identify any impurities. The system was equipped with<br />
a C 18 reversed phase column which was maintained at 50°C. The<br />
mobile phase was a mixture of 5 mM SDS in 20 mM<br />
KH 2 PO 4 :acetonitrile (65:35, v:v) at a flow rate of 1.0 mL/min. In<br />
addition to HPLC analysis, samples were also analyzed using electron<br />
microscopy, color tests, FTIR with golden gate, GC-MS and TLC in an<br />
attempt to determine the nature of any impurities present.<br />
Results: The purity of samples containing Ketamine only ranged<br />
between 65%—100% (mean = 87.9%; SD = 11.66%). Benzocaine was<br />
the principal impurity detected and ranged between 2.75%—16.60%<br />
(mean = of 7.27%; SD = 3.96%). Ketamine in samples containing<br />
Benzocaine ranged between 49.9% - 84% (mean = 67.21%;<br />
SD = 9.71%).<br />
Conclusion: The majority of street ketamine samples were of high<br />
percentage purity suggesting that ketamine may be responsible for<br />
effects on the urogenital system. This also supports the observation that<br />
a number of patients undergoing clinical therapy with ketamine have<br />
reported similar symptoms.<br />
Ketamine use is increasing rapidly worldwide and knowledge<br />
concerning the availability, purity, and trends in drug use can be of<br />
assistance to drug enforcement/legislation agencies as well as healthcare<br />
workers who may be involved in the provision of care to individuals<br />
following drug use. The results of this survey would support a<br />
hypothesis that bladder related diseases observed in ketamine users is<br />
likely to be attributable to ketamine rather than impurities or<br />
cutting agents.<br />
Ketamine, Purity, Bladder Disorders<br />
K9 Confirmation of Oleander Poisoning<br />
by LC/MS<br />
Beril Anilanmert, PhD, Istanbul University, Institute of Forensic Sciences,<br />
Istanbul, 34303, TURKEY; Musa Balta, MD, Istanbul University,<br />
Cerrahpasa <strong>Medical</strong> Faculty, Internal Emergency Department, Istanbul,<br />
34303, TURKEY; Muhammed Aydin, BSc, Istanbul University, Institute of<br />
Forensic Sciences, Istanbul, 34303, TURKEY; Isil Bavunoglu, MD,<br />
Istanbul University, Cerrahpasa Faculty of Medicine, Internal Emergency<br />
Department, Istanbul, 34303, TURKEY; Salih Cengiz, PhD*, Istanbul<br />
University, Institute of Forensic Sciences, Istanbul, 34300, TURKEY; and<br />
Zeynep Turkmen, MS, Istanbul University, Institute of Forensic Sciences,<br />
Cerrahpasa, Istanbul, 34303, TURKEY<br />
After attending this presentation, attendees will understand how to<br />
confirm oleander poisoning cases from blood and urine specimens.<br />
This presentation will impact the forensic science community by<br />
providing the toxicological data necessary to make diagnostic decision<br />
about the patient when oleandrin is detected by toxicological screening.<br />
In this case a 60-year-old woman was brought to emergency room<br />
with initial symptoms of vomiting, diarrhea, and abdominal pain. The<br />
patient’s heart beat was normal at the beginning but then sinus<br />
bradycardia was observed gradually. Information obtained from her<br />
indicated that she is a cancer patient and that she drank the juice of some<br />
leaves of the oleander plant (Nerium oleander L. - Apocynaceae) for<br />
herbal self treatment. Nerium oleander L. is a member of Apocynaceae<br />
family. Leaves from Nerium oleander were shown to contain 0.018 to<br />
0.425% oleandrin (weight/wet weight). Oleander extracts have been<br />
used for the treatment of indigestion, malaria, leprosy, mental or venereal<br />
diseases but the unconscious usage may cause toxicity.<br />
Blood and urine sample on admission was assayed for oleandrin,<br />
the major cardiac glycoside of N. oleander, which has a wide<br />
geographical range and ecological distribution throughout the world and<br />
also in Turkey. Both specimens were extracted with ethylacetate: nheptan<br />
(1:1) solvent mixture at 9.5 pH. Additionally, some parts of the<br />
oleander plant such as one flower, two leaves and one bark were chosen<br />
for extraction. These parts were cut and crushed in a 50 mL flacon to<br />
obtain about 2 mL sticky juice and then this was diluted with 3 mL water<br />
and extracted with the same solvent mixture.<br />
All separated specimens were performed on a highly specific LC-<br />
MS procedure with gradient elution. Using this analytical setting, the<br />
average retention time for oleandrin was 0.9 min. The major ions<br />
monitored for oleandrin were m/z 577 and 433 indicating total molecular<br />
weight and without glycosides form, respectively. The highest<br />
sensitivity for this assay was obtained with 70 eV.<br />
Qualitative results of the blood and urine samples on admission were<br />
compared with the plant extracts. Also qualitative result of the blood<br />
sample with urine sample was compared with each other. The most<br />
important thing was that the patient recovered without using any digoxin<br />
antibody such as Digifab or Digibind.<br />
This procedure provided the toxicological data necessary to make<br />
diagnostic decisions about the patient when oleandrin was detected by<br />
toxicological screening. Also LC-MS appears to be the method of choice<br />
for the forensic-toxicological investigation of poisonings by cardiac<br />
glycosides.<br />
Oleandrin, Poisoning, LC/MS<br />
5 * Presenting Author